Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
Atsuko Mizuno(Megmilk Snow Brand (Japan)), Kanji Higashio(Megmilk Snow Brand (Japan)), Takeshi Kanno(Jichi Medical University), Toshio Suda(Chinese Academy of Sciences), Masahiko Kinosaki(Megmilk Snow Brand (Japan)), Akihiko Murakami(SHOWA Medical University), Hisataka Yasuda(SHOWA Medical University), Kazuki Yano(SHOWA Medical University), Osamu Shibata, Nobuaki Fujise(Megmilk Snow Brand (Japan)), Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), M. Hoshi(Megmilk Snow Brand (Japan))
Cited by 147
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771